Use of drug combinations for treating insulin resistance
US8673964B2 · kind B2 · utility
1Cited by
2References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 20, 2005 |
| Grant date | Mar 18, 2014 |
| Priority date | — |
| Expiry date | Jan 16, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides pharmaceutical compositions comprising: (a) a modulator of hepatic parasympathetic tone, (b) at least one diabetes drug, and (c) a pharmaceutically acceptable carrier. The present invention includes methods for the treatment and/or prevention of insulin resistance, type 2 diabetes, impaired glucose intolerance, and other associated disorders with pharmaceutical compositions described herein. The invention also provides for a kit comprising a pharmaceutical composition and instructions for its use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.